Torrent Pharmaceuticals (TORNTPHARM) Share Price Falls 2.34% as Large Cap Valuation Stays in Focus
- September 3, 2026
- Posted by: Kunal Singla
- Category: News
Torrent Pharmaceuticals Share Price was under pressure today, with Torrent Pharmaceuticals Share Price moving to Rs 4,600 after a 2.34% decline and a market capitalisation of Rs 1,81,739.76 crore. According to Univest data, the move keeps Torrent Pharmaceuticals Share Price in focus as a large cap healthcare name, even though no company-specific catalyst is established. The stock opened at Rs 4,710, touched a high of Rs 4,729.65 and a low of Rs 4,600, which places the latest print at the day’s low. For readers tracking Torrent Pharmaceuticals Share Price Today, the numbers show a clear price fall, while Torrent Pharmaceuticals Stock News remains driven by valuation, sector placement and peer comparison rather than a fresh event explanation. As of 08 October 2026 at 2:53:07 PM IST, Torrent Pharmaceuticals Share Price is being watched for what the move means relative to its own fundamentals and the broader pharmaceuticals set.
Torrent Pharmaceuticals (TORNTPHARM) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 4,600 |
| Previous Close | Rs 4,710 |
| Today's Move | -Rs 110.00 (-2.34%) |
| Open | Rs 4,710 |
| High | Rs 4,729.65 |
| Low | Rs 4,600 |
| Market Capitalisation | Rs 1,81,739.76 crore |
| Market Cap Category | Large Cap |
Torrent Pharmaceuticals Share Price Today reflects a straightforward intraday decline from the previous close of Rs 4,710 to Rs 4,600, a fall of Rs 110 or 2.34%. The stock opened at the previous close, touched Rs 4,729.65 in early trade and then moved down to Rs 4,600, where Torrent Pharmaceuticals Share Price was last traded. That places the current print at the low of the day, with the market capitalisation at Rs 1,81,739.76 crore. Because the company is a Large Cap, Torrent Pharmaceuticals Share Price Update is best read alongside its broader valuation and industry context rather than as a small-move event. According to latest Univest figures, the latest session decline is meaningful enough to keep Torrent Pharmaceuticals Share Price in active market discussion. The price action now leads naturally into Torrent Pharmaceuticals Fundamental Analysis.
Torrent Pharmaceuticals (TORNTPHARM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,81,739.76 crore |
| P/E Ratio | 82.14x |
| P/B Ratio | 19.96x |
| ROE | 26.76% |
| ROCE | 19.27% |
| EPS | Rs 57.34 |
| Book Value Per Share | Rs 235.97 |
| Dividend Yield | 0.81% |
Torrent Pharmaceuticals (TORNTPHARM) fundamental metrics show P/E 82.14x, P/B 19.96x, ROE 26.76%, ROCE 19.27%. These figures provide context only and are not a buy or sell signal.
Torrent Pharmaceuticals has a market capitalisation of Rs 1,81,739.76 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 82.14x, P/B at 19.96x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 26.76% and ROCE of 19.27%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 57.34, book value per share of Rs 235.97, dividend yield of 0.81%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.87x, median ROE of 11.61%, median ROCE of 13.46%. Taken together, they outline the fundamentals rather than a view on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 82.14x |
| Benchmark Median P/E | 31.87x |
| Benchmark Average P/E | 48.48x |
| Benchmark P/E Range | 3.58x to 708.87x |
| Company P/B Ratio | 19.96x |
| Benchmark Median P/B | 2.98x |
| Benchmark Average P/B | 4.31x |
| Company ROE | 26.76% |
| Benchmark Median ROE | 11.61% |
| Benchmark Average ROE | 10.59% |
| Company ROCE | 19.27% |
| Benchmark Median ROCE | 13.46% |
| Benchmark Average ROCE | 13.36% |
| Company Market Capitalisation | Rs 1,81,739.76 crore |
| Benchmark Median Market Cap | Rs 854.81 crore |
| Benchmark Average Market Cap | Rs 14,121.7 crore |
Torrent Pharmaceuticals (TORNTPHARM) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Torrent Pharmaceuticals (TORNTPHARM) has a P/E ratio of 82.14x, which is above the benchmark median of 31.87x, a difference of +157.73%. On its own, the P/E gap is a valuation reference point, not a trading call.
Torrent Pharmaceuticals (TORNTPHARM) has a ROE of 26.76%, which is above the benchmark median of 11.61%, a difference of +130.49%. Torrent Pharmaceuticals (TORNTPHARM) has a ROCE of 19.27%, which is above the benchmark median of 13.46%, a difference of +43.16%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,32,120.23 | 35.37 | 4.95 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,53,389.76 | 86.95 | 14.4 | 16.19 | 21.51 |
| Zydus Lifesciences | ZYDUSLIFE | 1,15,710.44 | 25.51 | 4.27 | 19.69 | 21.39 |
| Laurus Labs | LAURUSLABS | 1,10,980.13 | 101.55 | 19.69 | 18.31 | 18.2 |
| Cipla | CIPLA | 1,08,497.02 | 31.87 | 3.06 | 11.83 | 16 |
Torrent Pharmaceuticals (TORNTPHARM) has a P/E ratio of 82.14x compared with the displayed peer median of 35.37x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 26.76% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 19.27% versus the displayed peer median of 19.11%, providing a capital-efficiency comparison. Torrent Pharmaceuticals (TORNTPHARM) has a market capitalisation of Rs 1,81,739.76 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching Torrent Pharmaceuticals
- Torrent Pharmaceuticals Share Price fell 2.34% to Rs 4,600, keeping the stock in focus for today’s price action.
- The Large Cap market capitalisation of Rs 1,81,739.76 crore gives Torrent Pharmaceuticals Share Price significant sector weight.
- P/E of 82.14 and P/B of 19.96 make Torrent Pharmaceuticals Share Price a valuation-led discussion point.
- ROE of 26.76% and ROCE of 19.27% remain stronger than the industry median in Torrent Pharmaceuticals Fundamental Analysis.
- The stock trades in a competitive pharmaceuticals peer set, so Torrent Pharmaceuticals Share Price today is best read against sector benchmarks.
About Torrent Pharmaceuticals
Torrent Pharmaceuticals operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is part of the Large Cap segment and is positioned among India’s established listed drug makers. Torrent Pharmaceuticals Share Price reflects a business that is evaluated through product portfolio strength, earnings quality and sector valuation rather than only day-to-day price moves. According to Univest data, the company’s published financial ratios show strong return metrics, a premium valuation and a meaningful market capitalisation. For investors reviewing Torrent Pharmaceuticals Share Price News, the company overview matters because it helps explain why the stock is compared directly with large listed pharmaceutical peers.
Track Torrent Pharmaceuticals Share Price on Univest
Use Torrent Pharmaceuticals (TORNTPHARM) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Track Torrent Pharmaceuticals Share Price live on Univest for day-wise movement, valuation ratios, market capitalisation, 52-week levels and company updates. Univest also brings together Torrent Pharmaceuticals Stock Analysis, Torrent Pharmaceuticals Latest News and Torrent Pharmaceuticals Fundamental Analysis in one place. For readers following Torrent Pharmaceuticals Share Price Today, the platform provides a quick way to review price action and compare the stock with sector peers without losing the broader context.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Torrent Pharmaceuticals Share Price falling today?
Ans. Torrent Pharmaceuticals Share Price fell 2.34% to Rs 4,600 after trading between Rs 4,729.65 and Rs 4,600. According to Univest data, the price event is confirmed, but no company-specific catalyst is established.
What is Torrent Pharmaceuticals Share Price Today?
Ans. Torrent Pharmaceuticals Share Price Today is Rs 4,600. The stock is down Rs 110 from the previous close of Rs 4,710, and the move keeps Torrent Pharmaceuticals Stock News and price action in focus.
What does Torrent Pharmaceuticals Fundamental Analysis show?
Ans. Torrent Pharmaceuticals Fundamental Analysis shows a P/E of 82.14, P/B of 19.96, ROE of 26.76%, ROCE of 19.27%, EPS of Rs 57.34 and book value of Rs 235.97. Dividend yield is 0.81%.
How does Torrent Pharmaceuticals compare with sector benchmarks?
Ans. Torrent Pharmaceuticals Share Price trades at a P/E above the industry median of 31.87 and average of 48.48. Its ROE and ROCE are also above benchmark medians, while valuation remains richer than the sector centre.
Is Torrent Pharmaceuticals a Large Cap company?
Ans. Yes, Torrent Pharmaceuticals is classified as a Large Cap company. Its market capitalisation is Rs 1,81,739.76 crore, which places Torrent Pharmaceuticals Share Price among the larger names in Healthcare and Pharmaceuticals & Drugs.
How does Torrent Pharmaceuticals Share Price compare with peers?
Ans. Torrent Pharmaceuticals Share Price has a market capitalisation below Sun Pharma and Divi’s Laboratories, but above many other peers listed here. Its P/E is also higher than most comparables, while ROE remains strong.
What are the key valuation ratios for Torrent Pharmaceuticals Share Price?
Ans. The key valuation ratios are P/E of 82.14 and P/B of 19.96. In Torrent Pharmaceuticals Share Price analysis, these numbers suggest a premium valuation versus the broader pharmaceuticals benchmark. The previous close was Rs 4,710.
What should investors watch next in Torrent Pharmaceuticals Share Price?
Ans. Investors tracking Torrent Pharmaceuticals Share Price should watch whether the stock holds around Rs 4,600, how it compares with its prior close of Rs 4,710, and whether valuation stays aligned with sector peers.
Where can I track Torrent Pharmaceuticals Share Price on Univest?
Ans. Univest provides Torrent Pharmaceuticals Share Price tracking with live updates, market capitalisation, fundamentals, 52-week levels and stock insights. It is a convenient place to follow Torrent Pharmaceuticals Stock Analysis and Company News in one view.